Neumora Therapeutics, Inc. (NMRA)
NASDAQ: NMRA · Real-Time Price · USD
1.720
+0.050 (2.99%)
Jul 6, 2026, 12:20 PM EDT - Market open
Neumora Therapeutics Employees
Neumora Therapeutics had 92 employees as of March 31, 2026. The number of employees decreased by 4 or -4.17% since the number was last reported on December 31, 2025.
Employees
92
Change
-4
Growth
-4.17%
Revenue / Employee
n/a
Profits / Employee
-$2,417,326
Market Cap
318.69M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 92 | -4 | -4.17% |
| Dec 31, 2025 | 96 | -14 | -12.73% |
| Dec 31, 2024 | 110 | -14 | -11.29% |
| Dec 31, 2023 | 124 | 30 | 31.91% |
| Dec 31, 2022 | 94 | 6 | 6.82% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| MacroGenics | 293 |
| Bicycle Therapeutics | 288 |
| Lyell Immunopharma | 161 |
| Adagene | 128 |
| Foghorn Therapeutics | 106 |
| Zentalis Pharmaceuticals | 106 |
| SAB Biotherapeutics | 86 |
| Cartesian Therapeutics | 75 |
NMRA News
- 18 days ago - Neumora Therapeutics price target lowered to $4 from $6 at Mizuho - TheFly
- 19 days ago - Neumora Therapeutics Slides: Investor presentation - Filings
- 20 days ago - Neumora Therapeutics price target lowered to $5 from $8 at Needham - TheFly
- 20 days ago - Neumora Therapeutics price target lowered to $7 from $18 at H.C. Wainwright - TheFly
- 20 days ago - Clear Street says Neumora failed trial does not impact LB Pharmaceuticals LB-102 - TheFly
- 21 days ago - Neumora Therapeutics announces KOASTAL studies miss primary endpoint - TheFly
- 21 days ago - Neumora Therapeutics scraps depression drug after two late-stage trial failures - Reuters
- 21 days ago - Neumora Therapeutics Reports Data from Phase 3 KOASTAL Program and Provides Business and Pipeline Update - GlobeNewsWire